Implementation and Evaluation of Tailored Interventions to Increase MMR and/or HPV Vaccine

Summary

The goal of the study is to monitor and evaluate the implementation of interventions that aim to increase HPV \& MMR vaccines among underserved communities across four European countries: Greece, Netherlands, Poland, and Slovakia. The interventions will target identified health systems barriers in an earlier phase of the project. The interventions that will be implemented employ trusted community members as health promotors whom will provide educational sessions on HPV and MMR vaccination to the target groups. In addition, the cost-effectiveness of vaccine uptake strategies for the target groups is being evaluated.

The main research question is: to what extent is the multicomponent tailored intervention effective to increase MMR/HPV intention and vaccine uptake in the target population in Greece, Netherlands, Poland and Slovakia?

Conditions

• Vaccination
• Health Systems
• Knowledge, Attitudes, Practice

Interventions

BEHAVIORAL

multicomponent intervention on vaccination awareness

Educational sessions to create awareness on HPV and MMR (were addressed) vaccination that is culturally sensitive health information and provided in an easily understandable manner by trained health promoters (and healthcare professionals) to underserved communities. Support for navigation and access to vaccines.

Sponsors & Collaborators

• Prolepsis Institute for Preventive, Environmental and Occupational Medicine

  collaborator OTHER

• University in Zielona Góra

  collaborator OTHER

• Pavol Jozef Safarik University

  collaborator OTHER

• University Medical Center Groningen

  lead OTHER

Principal Investigators

• Nikole Papaevgeniou, PhD · Prolepsis Institute for Preventive, Environmental and Occupational Medicine

• Daniela Fiľakovská, PhD · UPJS

• Maria Ganczak, MD PhD · University Zielona Gora

• Michael Edelstein, MD PhD · Bar Ilan University

• Cornelis Boersma, PhD · UMCG

Study Design

Allocation

NON_RANDOMIZED

Purpose

HEALTH_SERVICES_RESEARCH

Masking

NONE

Model

SINGLE_GROUP

Eligibility

Min Age

12 Years

Max Age

100 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2024-05-01

Primary Completion

2025-06-01

Completion

2025-06-01

Countries

• Greece
• Netherlands
• Poland
• Slovakia

Study Locations